A detailed history of Sofinnova Investments, Inc. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 2,194,278 shares of YMAB stock, worth $17.8 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
2,194,278
Previous 2,194,278 -0.0%
Holding current value
$17.8 Million
Previous $26.5 Million 8.69%
% of portfolio
2.73%
Previous 1.47%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

BUY
$23.81 - $33.78 $2.14 Million - $3.04 Million
90,000 Added 4.28%
2,194,278 $68.6 Million
Q3 2018

Nov 15, 2018

BUY
$24.0 - $26.97 $50.5 Million - $56.8 Million
2,104,278 New
2,104,278 $55.9 Million

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $355M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Sofinnova Investments, Inc. Portfolio

Follow Sofinnova Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sofinnova Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sofinnova Investments, Inc. with notifications on news.